COMPANY
Zena Therapeutics
NIH awards 2
- NIH award 3R41DA058472-01S1 FY2024: $55,000 awarded for that fiscal year; activity R41 (STTR); PI CARRY, EILEEN; recipient as written: ZENA THERAPEUTICS INC., PRINCETON, NJ. Development of compound RUEC2-118, a novel source ↗
- NIH award 1R41DA058472-01 FY2023: $313,300 awarded for that fiscal year; activity R41 (STTR); PI CARRY, EILEEN; recipient as written: ZENA THERAPEUTICS INC., PRINCETON, NJ. Development of compound RUEC2-118, a novel source ↗